T1	Intervention 157 192	advanced colorectal cancer patients
T2	Intervention 615 694	advanced colorectal cancer (ACC) patients treated in the phase III CAIRO2 study
T3	Intervention 718 780	Seven hundred and fifty five previously untreated ACC patients
